GlassScriptPhysician profile
Richard A Young
NPI 1881664423
$1,243.37
in general payments reported to CMS, 2019-2025
21 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.37 · 2020: $14.79 · 2021: $145 · 2022: $328 · 2023: $174 · 2024: $168 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $180.78 | 2019-2025 | Grafix Pl, Allevyn Life L 15.4x15.4 Ctn10 |
| Tactile Systems Technology INC | $178.74 | 2022 | |
| Abbvie INC. | $170.07 | 2023-2025 | Dalvance |
| Kerecis Limited | $165.14 | 2019-2021 | |
| Bioventus LLC | $68.81 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Hydrofera LLC | $68.73 | 2024-2025 | Hydrofera Blue, Leukomed Sorbact |
| Grt US Holding, INC. | $65.34 | 2022 | |
| Abbott Laboratories | $55.09 | 2022-2025 | Proclaim |
| Hartmann USA, INC. | $43.50 | 2025 | Colactive Plus 2x2, Zetuvit Plus 10x10 P10 |
| Pacira Pharmaceuticals Incorporated | $29.34 | 2023 | Iovera, Zilretta, Exparel |
| Solventum Corporation | $24.41 | 2025 | Activ.A.C. |
| Acera Surgical, INC. | $24.25 | 2025 | Restrata Wound Matrix |
| Paratek Pharmaceuticals, INC. | $23.04 | 2024 | Nuzyra |
| Stryker Corporation | $21.32 | 2024 | Inspace |
| Vertex Pharmaceuticals Incorporated | $21.20 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $20.86 | 2025 | Miro3d |
| Treace Medical Concepts, INC. | $19.39 | 2023 | |
| Integra Lifesciences Corporation | $17.73 | 2024 | Tcc-Ez |
| Organogenesis INC. | $16.39 | 2024 | |
| Merck Sharp & Dohme LLC | $15.49 | 2019 | |
| Misonix INC | $13.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.